Option Care Health (OPCH) Stock: Buy, Sell, or Hold?
OPCH - Option Care Health, Inc. Common Stock
$22.64
0.06 (0.27%)
▲
5d:
-1.86%
30d:
-5.07%
90d:
+5.99%
HOLD
MODERATE Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Oct 29, 2026
25d
Get Alerted When OPCH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: OPCH shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: OPCH shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$39.74
Based on 7.4% avg growth
INTRINSIC VALUE TODAY
$24.68
8.3% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 13.4x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: OPCH is currently trading at $22.64, which is considered oversold relative to its 30-day fair value range of $23.10 to $24.19. From a valuation perspective, the stock is trading at a discount (Forward PE: 10.9) compared to its historical average (13.4). Remarkably, the market is currently pricing in an annual earnings decline of 6.7% over the next few years. This pessimistic expectation contrasts with the company's recent 12.9% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, OPCH is in a strong uptrend. The price is currently testing key support at $22.29. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 59/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $28.58 (+26.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, OPCH is in a strong uptrend. The price is currently testing key support at $22.29. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 59/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $28.58 (+26.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$23.10 -
$24.19
Company Quality Score
62/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
79.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (59/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 26.3% below Wall St target ($28.58)
- NEUTRAL: Bottoming setup forming (59/100) — watch for confirmation
Trading Range Analysis
30-Day Trading Range
$23.10 -
$24.19
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$22.29
Resistance Level
$24.48
Current Trend
Strong Uptrend
Technical data as of
Oct 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
10.87
Wall Street Target
$28.58
(+26.3%)
Revenue Growth (YoY)
1.9%
Earnings Growth (YoY)
12.9%
Profit Margin
3.7%
Valuation Discount vs History
-6.7% cheaper
PE vs Historical
10.9 vs 13.4
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-6.7%
(market-implied from PE analysis)
1-Year Target
$21.12
(-7%)
2-Year Target
$19.71
(-13%)
3-Year Target
$18.39
(-19%)
3-Yr Target (if PE normalizes)
(PE: 11→13)
$22.67
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.4, Growth: 10.7%)
$57.58
(+154%)
Base:
(SPY PE: 10.9, Growth: 10.7%)
$30.68
(+36%)
Bear:
(PE: 9.2, Growth: 10.7%)
$26.08
(+15%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (17x PE), but valuation improves significantly next year (11x PE) as earnings recover.
Trailing PE: 16.98 | Current EPS (TTM): $1.33
Bull Case
$38.90
(+72%)
Analyst growth 56.6%, PE expands to 18.7
Base Case
$35.36
(+56%)
Market implied 56.6%, PE stable at 17.0
Bear Case
$15.35
(-32%)
Severe decline -20.0%, PE contracts to 14.4
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 10.9 to 13.4
Stabilization Target:
$27.91
(+23.3%)
PE Expansion Potential:
+23.3%
Share & Embed Analysis
Last updated: October 03, 2026 9:34 AM ET
Data refreshes hourly during market hours. Next update: 10:34 AM
Data refreshes hourly during market hours. Next update: 10:34 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is OPCH showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
22 analysts |
$285 | 61 BUY |
|
HCA
HCA Healthcare, Inc. |
BUY
25 analysts |
$454 | 48 HOLD |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$148 | 55 HOLD |
|
ADUS
Addus HomeCare Corporati… |
STRONG BUY
11 analysts |
$134 | 67 BUY |
|
CON
Concentra Group Holdings… |
STRONG BUY
8 analysts |
$41 | 61 BUY |
